Tandem Diabetes Care, Inc. (TNDM)
NASDAQ: TNDM · Real-Time Price · USD
20.92
+0.21 (1.01%)
At close: Dec 5, 2025, 4:00 PM EST
21.31
+0.39 (1.86%)
After-hours: Dec 5, 2025, 7:38 PM EST
Tandem Diabetes Care Revenue
Tandem Diabetes Care had revenue of $249.25M in the quarter ending September 30, 2025, with 2.17% growth. This brings the company's revenue in the last twelve months to $1.01B, up 17.87% year-over-year. In the year 2024, Tandem Diabetes Care had annual revenue of $940.20M with 25.74% growth.
Revenue (ttm)
$1.01B
Revenue Growth
+17.87%
P/S Ratio
1.39
Revenue / Employee
$380,000
Employees
2,650
Market Cap
1.42B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 940.20M | 192.49M | 25.74% |
| Dec 31, 2023 | 747.72M | -53.50M | -6.68% |
| Dec 31, 2022 | 801.22M | 98.42M | 14.00% |
| Dec 31, 2021 | 702.80M | 203.97M | 40.89% |
| Dec 31, 2020 | 498.83M | 136.53M | 37.68% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
TNDM News
- 24 days ago - Tandem Diabetes Care Announces Appointment of Sandra Beaver to Board of Directors - Business Wire
- 26 days ago - Tandem Mobi Receives FDA Clearance for Use with Android Smartphones - Business Wire
- 4 weeks ago - Tandem Diabetes Care, Inc. (TNDM) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Tandem Diabetes Care Announces Third Quarter 2025 Financial Results - Business Wire
- 4 weeks ago - Tandem Diabetes Care Achieves ISO/IEC 27001:2022 Certification, Reinforcing Commitment to Global Data Security Standards - Business Wire
- 5 weeks ago - Tandem Diabetes Care Announces Upcoming Conference Presentations - Business Wire
- 5 weeks ago - t:slim X2™ Insulin Pump Now Available with Abbott's FreeStyle Libre® 3 Plus Sensor in the United States - Business Wire
- 7 weeks ago - TNDM Investors Have Opportunity to Join Tandem Diabetes Care, Inc. Fraud Investigation with the Schall Law Firm - PRNewsWire